The company said its revenue growth was supported by an 8% increase in underlying volumes.
Biosimilars revenue grew 18% YoY to ₹2,458 crore in the quarter. This growth was driven by sustained global demand
The company’s operating performance saw a notable improvement. EBITDA jumped 30.2% to ₹56 crore. This is compared to ₹43 crore in Q1FY25.
Additionally, the company announced that its Retail APE was reported at ₹7,061 Crore. This came in higher than street estimates of ₹6,919 Crore.
On the operational front, EBITDA rose 38.6% YoY to ₹525 crore. This is against ₹379 crore a year ago.
Revenue for the quarter rose modestly to ₹6,560 crore, a 3.6% increase over ₹6,334 crore reported a year earlier.
Revenue from operations rose 13.2% YoY to ₹3,826 crore. This surge is up from ₹3,378 crore in the corresponding quarter of the previous fiscal.
The Consumerware industry refers to the market for products and services that cater to the daily needs of households and individuals.
Indian equity indices ended marginally higher on August 7.
Here are some of the stocks that may see significant price movement: Life Insurance Corporation, Godrej Consumer, Titan Company, etc.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor), PFRDA Reg. No. PoP 20092018
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
